Skip to main content

Mochida Pharmaceutical

Mochida Pharmaceutical Co Ltd is a Japanese pharmaceutical company developing, manufacturing, and marketing prescription drugs, medical devices, and skincare products. The company specializes in cardiovascular medicine, obstetrics, gynecology, analgesics, and immunology, producing flagship products such as Epadel (ethyl icosapentate) for hyperlipidemia and Lube, alongside medical ultrasound diagnostic equipment. Principal revenues derive from direct product sales of prescription pharmaceuticals and medical equipment to hospital networks, medical wholesalers, and retail pharmacies across Japan. Core end markets encompass cardiovascular specialty clinics, gynecology departments, hospital networks, and prescription patients in Japan. Mochida Pharmaceutical holds an established position in Japan's prescription pharmaceutical industry for cardiovascular and women's health therapeutics. The company is headquartered in Tokyo, Japan, and its common stock trades on the Prime Market of the Tokyo Stock Exchange.

3 of the funds FundTelligence covers report a position in Mochida Pharmaceutical.

Legal name
Mochida Pharmaceutical Co Ltd
Sector
Health Care
Country
Japan
Funds holding it
3

Funds holding Mochida Pharmaceutical

Loading...